Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials. (2022)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00198-022-06483-y
PubMed Identifier: 35833956
Publication URI: http://europepmc.org/abstract/MED/35833956
Type: Journal Article/Review
Volume: 33
Parent Publication: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Issue: 11
ISSN: 0937-941X